Literature DB >> 9554904

North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.

M Eccles1, N Freemantle, J Mason.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9554904      PMCID： PMC1113035          DOI： 10.1136/bmj.316.7140.1303

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  92 in total

1.  [Treatment of unstable angina with dipyridamole combined with low doses of aspirin. A multicenter pilot double-blind controlled study].

Authors:  P Prandoni; L Milani; M Barbiero; P Cardaioli; A Sanson; F Barbaresi; P Zonzin; L Visani
Journal:  Minerva Cardioangiol       Date:  1991 Jul-Aug       Impact factor: 1.347

2.  Clinical study of ticlopidine in diabetic retinopathy. Belgian Ticlopidine Retinopathy Study Group (BTRS).

Authors: 
Journal:  Ophthalmologica       Date:  1992       Impact factor: 3.250

3.  Effects of early intervention with low-dose aspirin (100 mg) on infarct size, reinfarction and mortality in anterior wall acute myocardial infarction.

Authors:  F W Verheugt; A van der Laarse; A J Funke-Küpper; L G Sterkman; T W Galema; J P Roos
Journal:  Am J Cardiol       Date:  1990-08-01       Impact factor: 2.778

4.  Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1991-11-30       Impact factor: 79.321

5.  Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

6.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.

Authors:  B Farrell; J Godwin; S Richards; C Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

7.  Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischaemia. The Research Group on Instability in Coronary Artery Disease in Southeast Sweden.

Authors:  I Nyman; H Larsson; L Wallentin
Journal:  Lancet       Date:  1992-08-29       Impact factor: 79.321

8.  Ticlopidine treatment for patients with unstable angina at rest. A further analysis of the study of ticlopidine in unstable angina. Studio della Ticlopidina nell'Angina Instabile Group.

Authors:  D Scrutinio; R Lagioia; P Rizzon
Journal:  Eur Heart J       Date:  1991-12       Impact factor: 29.983

9.  Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators.

Authors: 
Journal:  JAMA       Date:  1992-09-09       Impact factor: 56.272

10.  Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden.

Authors:  L C Wallentin
Journal:  J Am Coll Cardiol       Date:  1991-12       Impact factor: 24.094
View more
  8 in total

1.  Developing valid cost effectiveness guidelines: a methodological report from the north of England evidence based guideline development project.

Authors:  M Eccles; J Mason; N Freemantle
Journal:  Qual Health Care       Date:  2000-06

2.  A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice.

Authors:  Nick Freemantle; Irwin Nazareth; Martin Eccles; John Wood; Andrew Haines
Journal:  Br J Gen Pract       Date:  2002-04       Impact factor: 5.386

3.  Aspirin prophylaxis for vascular disease. Knowledge needs to be used in clinical situations.

Authors:  D Fitzmaurice; C P Thomas
Journal:  BMJ       Date:  1998-11-07

4.  Extrapolation of trial results suggests that aspirin is useful in intermittent claudication.

Authors:  P Gresele; R Migliacci
Journal:  BMJ       Date:  1998-12-05

Review 5.  Pharmacological treatment of elderly patients with acute coronary syndromes without persistent ST segment elevation.

Authors:  Manesh R Patel; Matthew T Roe
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

6.  The clinical and economic impact of a secondary heart disease prevention clinic jointly implemented by a practice nurse and pharmacist.

Authors:  Val Reilly; Margaret Cavanagh
Journal:  Pharm World Sci       Date:  2003-12

7.  Regulations of the key mediators in inflammation and atherosclerosis by aspirin in human macrophages.

Authors:  Li Lu; Hong Liu; Jiahe Peng; Lin Gan; Lili Shen; Qian Zhang; Liangpeng Li; Li Zhang; Chang Su; Yu Jiang
Journal:  Lipids Health Dis       Date:  2010-02-06       Impact factor: 3.876

8.  Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study.

Authors:  D A Lawlor; C Bedford; M Taylor; S Ebrahim
Journal:  J Epidemiol Community Health       Date:  2003-02       Impact factor: 3.710
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.